Search - tctmd.com

Displaying 241 - 260 of 313

Sort: Relevancy | Date

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2019

Shelley Wood

March 29, 2019

Presentation SIF 2019

Women & Heart Disease

Presenter: Danielle Stearns

March 29, 2019

Presentation SIF 2019

Endovascular Electrosurgery Basilica and Lampoon

Presenter: Michael Rinaldi

March 29, 2019

Presentation SIF 2019

Left Atrial Appendage Closure is an Under-Utilized Therapy

Presenter: Brij Maini

March 27, 2019

Presentation SIF 2019

Closing a Hole in the Heart

Presenter: David G. Rizik

March 27, 2019

Presentation ECHO/IMAGING 2019

Constrictive Pericarditis - Curable Paradoxical Diastolic Heart Failure

Presenter: Jae K. Oh

March 23, 2019

News Daily News

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

L.A. McKeown

March 15, 2019

News Conference News CRT 2019

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

Yael L. Maxwell

March 14, 2019

News Daily News

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

Todd Neale

March 14, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

L.A. McKeown

March 01, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

L.A. McKeown

March 01, 2019

News Daily News

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

Todd Neale

February 25, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

L.A. McKeown

February 19, 2019

Presentation JIM 2019

My Worst Complication: How to treat coronary aneurysm

Presenter: Akihiro Shirasaka

February 15, 2019

News Conference News ISC 2019

Window for IV Thrombolysis in Stroke May Stay Open Twice as Long With Imaging Selection

Todd Neale

February 14, 2019

Presentation JIM 2019

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Presenter: Maurice Buchbinder

February 14, 2019

News Daily News

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

L.A. McKeown

February 13, 2019

Advertisement

TCTMD’s Top 10 Most Popular Stories for March 2019

Women & Heart Disease

Endovascular Electrosurgery Basilica and Lampoon

Left Atrial Appendage Closure is an Under-Utilized Therapy

Closing a Hole in the Heart

Constrictive Pericarditis - Curable Paradoxical Diastolic Heart Failure

FDA Analysis Points to Higher Death Risk With Paclitaxel-Based Devices for PAD

SAFE-DCB Demonstrates Consistent Efficacy at 1 Year in Real-world Femoropopliteal Disease Patients

COMPASS Published: Experts See Level I Evidence in Support of Aspiration Thrombectomy for Stroke

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

A Day of Data: Signal of Mortality Increase With Paclitaxel Devices in PAD Continues to Vex

TCTMD’s Top 10 Most Popular Stories for February 2019

No Excess Mortality Risk With Paclitaxel Stents in PAD, Second Medicare Analysis Finds

When Is It Time to Abandon Thrombectomy for Acute Stroke? New Clues

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

Mortality Data ‘Inadvertently Omitted’ From IN.PACT Analysis of Paclitaxel-Coated Balloons

My Worst Complication: How to treat coronary aneurysm

Window for IV Thrombolysis in Stroke May Stay Open Twice as Long With Imaging Selection

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Medicare Analysis Offers More Reassurances in Hullabaloo Over Paclitaxel-Based PAD Devices

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content